Shorter Disease Duration Predicts Earlier Complete Skin Clearance in Biologic-naïve Psoriasis Treated with Biologics
Year: 2026
Type: article
Study design: Observational Study
Abstract: The association between psoriasis disease duration and complete skin clearance after biologic initiation remains uncertain. This single-centre retrospective study included 218 biologic-naïve patients who initiated biologic therapy between 2010 and 2024. Disease duration was defined as the interval from symptom onset to biologic initiation and categorized as ≤2 years or >2 years. Absolute Psoriasis Area and Severity Index (PASI) 0 was assessed at 3 months, 6 months, 1 year and 2 years using an as-observed approach. Twenty-nine patients (13.3%) had disease duration ≤2 years. At 3 months, absolute PASI 0 was achieved in 6/29 (20.7%) patients with shorter disease duration and 14/189 (7.4%) with longer disease duration (p=0.033). No significant differences were detected at subsequent assessments. In an exploratory multivariable Cox model including baseline PASI, shorter disease duration was associated with early PASI 0 achievement (hazard ratio 4.75; 95% confidence interval 1.57-14.40). Sparse early events and incomplete covariate data limit interpretation. Shorter disease duration was associated with earlier complete skin clearance; larger studies are needed to establish whether this association is independent of treatment selection and other confounders.
Source: Acta Dermato Venereologica
Institution: Teikyo University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,725
OpenAlex ID: W7236467910
